Erin Parker

Erin Parker is an accomplished professional in pharmacovigilance with extensive experience in leadership roles across various organizations. Currently serving as Vice President of Pharmacovigilance at Tempus Labs, Inc. since February 2023, Erin has held similar positions at Highline Sciences, Worldwide Clinical Trials, and Synteract, contributing to the evolving field of drug safety. Prior experience also includes significant roles at Novella Clinical. Erin's educational background includes a Master's of Science in Nursing from Vanderbilt University and a Post Master's in Clinical Research Management from Duke University, along with undergraduate studies at Emory University.